Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hallett David, holds the title of Chief Scientific Officer at RECURSION PHARMACEUTICALS, INC..
On 2026-11-16, the insider transacted 26,657 shares.The shares were transacted at a weighted average price of $3.19 per share, resulting in a total market-relevant value of $85K.
Hallett David (Chief Scientific Officer) had withheld for taxes $85K of $RXRX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.